What Our Partners Say
We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us.
Latest Articles on What Our Partners Say
What Our Partners Say
Our Partners: Warren Center for Neuroscience Drug Discovery at Vanderbilt University
Craig Lindsley, Director of the WCNDD talks about the challenges facing neuroscience researchers and the commitment of Boehringer Ingelheim to this important area.
What Our Partners Say
Our Partners: ViraTherapeutics
Lisa Egerer, COO and Patrik Erlmann, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
What Our Partners Say
Our Partners: Harvard Fibrosis Network
Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
Links
Boehringer Ingelheim Venture Fund
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.